Stock Price Quote

NORRIS MEDICINES LTD.

NSE : NABSE : 524414ISIN CODE : INE744C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE11.350.05 (+0.44 %)
PREV CLOSE ( ) 11.30
OPEN PRICE ( ) 11.30
BID PRICE (QTY) 11.40 (3700)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 41
TODAY'S LOW / HIGH ( )11.30 11.35
52 WK LOW / HIGH ( ) 10.0527.51
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-09 1990
Management Info
- Chairman Vimal Shah - Managing Director
Registered Office

Address Plot No. 801 / P,G I D C ,Industrial Estate,
Ankleshwar,
Gujarat-393002

Phone 02646 - 223462, 227530

Email secretarial@norrispharma.com

Website www.norrispharma.com

Registrars Details
Purva Shareregistry (India) Pvt Ltd
Gala No 9,Shiv Shakti, Industrial Estate,Sitaram Mill Comp.,J R Boricha Marg, Lower Parel [E],Mumbai
Listing : BSE

NEWS

22Mar Norris Medicines informs about outcome
Norris Medicines has informed that Independent Directors of Norris Medic..
29Sep Norris Medicines informs about closure
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, Nor..
14Jun Norris Medicines informs about issuanc
Pursuant to Reg.39 (3) of SEBI (Listing Obligations and Disclosure Requi..
13Feb Norris Medicines informs about outcome
Norris Medicines has informed that the Board of Directors at their Meeti..
11Nov Norris Medicines informs about unaudit
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit1.74-11.88
Gross Profit 2.63 -10.99
Operating Profit 5.13-1.57
Net Sales 14.8856.36

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  6838.70 (5.00%)
M.Cap ( in Cr)15749.95
Astrazeneca Pharma I (BSE)
peergroup  6492.00 (2.22%)
M.Cap ( in Cr)16203.50
NGL Fine-Chem (BSE)
peergroup  2388.80 (2.30%)
M.Cap ( in Cr)1485.81
Procter&Gamble Healt (BSE)
peergroup  5025.05 (0.74%)
M.Cap ( in Cr)8296.37
Strides Pharma Scien (BSE)
peergroup  977.00 (3.70%)
M.Cap ( in Cr)9037.71

Shareholding Pattern

NON-INSTITUTION 65.92%
PROMOTERS 34.01%
FI/BANKS/INSURANCE 0.06%
MUTUAL FUNDS/UTI 0.01%
GOVERNMENT 0%
FII 0%

About Norris Medicines Ltd.

Norris Medicines Ltd. was incorporated in the year 1990. Its today's share price is 11.35. Its current market capitalisation stands at Rs 11.35 Cr. In the latest quarter, company has reported Gross Sales of Rs. 83.58 Cr and Total Income of Rs.83.73 Cr. The company's management includes Prerna Karwa, Shaikh Amanullah Mohamed Azmathullah, Susmita Mahapatra, Vimal Shah.

It is listed on the BSE with a BSE Code of 524414 , NSE with an NSE Symbol of and ISIN of INE744C01029. It's Registered office is at Plot No. 801 / P,G I D C ,Industrial EstateAnkleshwar-393002, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bahedia & Associates, HN Jadav & Co, Minu Modi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.